ConductScience.org, home

Paper36980800

A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia.

Carbó JM and 10 others. Cancers (Basel), 2023. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia. Papers, record 36980800. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980800

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2024-09-15
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carbó JMJosé M
2Cornet-Masana JMJosep M
3Cuesta-Casanovas LLaia
4Delgado-Martínez JJenniferhttps://orcid.org/0000-0002-5962-3064
5Banús-Mulet AAntònia
6Clément-Demange LLisehttps://orcid.org/0000-0002-9360-1344
7Serra CCarmehttps://orcid.org/0000-0001-6643-3077
8Catena JJuanlohttps://orcid.org/0000-0002-2423-5926
9Llebaria AAmadeuhttps://orcid.org/0000-0002-8200-4827
10Esteve JJordi
11Risueño RMRuth Mhttps://orcid.org/0000-0003-4048-9536

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PRODUCTEAgency for Administration of University and ResearchPubMed
CaixaimpulseFundación Bancaria Caixa d'Estalvis i Pensions de BarcelonaPubMed
201930-30Fundació Marató TV3PubMed

Source PubMed

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,293,397Selective killing of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts.J Inherit Metab Dis1992https://conductscience.org/library/papers/1293397PubMed
232,014,868Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges.Cancer Discov2020https://conductscience.org/library/papers/32014868PubMed
335,582,535Lysosome-mediated chemoresistance in acute myeloid leukemia.Cancer Drug Resist2022https://conductscience.org/library/papers/35582535PubMed
431,915,366Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?Leukemia2020https://conductscience.org/library/papers/31915366PubMed
530,610,707Methods to Detect Loss of Lysosomal Membrane Integrity.Methods Mol Biol2019https://conductscience.org/library/papers/30610707PubMed
631,406,169Identification of a factor controlling lysosomal homeostasis using a novel lysosomal trafficking probe.Sci Rep2019https://conductscience.org/library/papers/31406169PubMed
733,634,751Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.Autophagy2021https://conductscience.org/library/papers/33634751PubMed
823,202,731Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.J Clin Invest2013https://conductscience.org/library/papers/23202731PubMed
931,473,184Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells.EBioMedicine2019https://conductscience.org/library/papers/31473184PubMed
1018,158,874Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells.Acta Pharmacol Sin2008https://conductscience.org/library/papers/18158874PubMed
1131,974,170Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.Cancer Discov2020https://conductscience.org/library/papers/31974170PubMed
1225,997,737Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies.Mol Cells2015https://conductscience.org/library/papers/25997737PubMed
1322,094,260Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.Cancer Cell2011https://conductscience.org/library/papers/22094260PubMed
1434,171,263The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance.Cancer Cell2021https://conductscience.org/library/papers/34171263PubMed
1532,315,388FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.Blood2020https://conductscience.org/library/papers/32315388PubMed
1630,546,014Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.Cell Death Dis2018https://conductscience.org/library/papers/30546014PubMed
1732,700,072The Time Has Come for Targeted Therapies for AML: Lights and Shadows.Oncol Ther2020https://conductscience.org/library/papers/32700072PubMed
1823,359,069Notch activation inhibits AML growth and survival: a potential therapeutic approach.J Exp Med2013https://conductscience.org/library/papers/23359069PubMed
1935,323,341Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review.Curr Oncol2022https://conductscience.org/library/papers/35323341PubMed
2029,420,223Oxidative Phosphorylation as an Emerging Target in Cancer Therapy.Clin Cancer Res2018https://conductscience.org/library/papers/29420223PubMed

See all 47 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
39,027,232Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer.Acta Pharm Sin B2024https://conductscience.org/library/papers/39027232PubMed
38,162,504Establishment of a lysosome-related prognostic signature in breast cancer to predict immune infiltration and therapy response.Front Oncol2023https://conductscience.org/library/papers/38162504PubMed
37,508,431Remodelling of the Mitochondrial Bioenergetic Pathways in Human Cultured Fibroblasts with Carbohydrates.Biology (Basel)2023https://conductscience.org/library/papers/37508431PubMed

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980800

GET https://conductscience.org/api/papers/v1/36980800/references?page=2